Naming CHO cells for bio-manufacturing: Genome plasticity and variant
phenotypes of cell populations in bioreactors question the relevance of
old names.
Abstract
Chinese Hamster Ovary [CHO] cells are the workhorse for production
of modern biopharmaceuticals, with total sales of CHO-produced proteins
exceeding 100 Billion US Dollars/year today. CHO cells are however
immortalised cells with a high propensity for genetic change. Judging
from published culture records, CHO cell populations have undergone
hundreds of population doublings since their origin in the late 1950s.
Different cell populations were established and named during the first
two decades after their generation, such as CHO-Pro-, CHO-K1, CHO-DG44,
CHO-S, CHO-DUK, CHO-DXB-11, CHO-LA, etc. to indicate origin and certain
phenotypic features. These names are commonly used in scientific
publications still today. This article tries to raise questions about
the relevance of such names. We argue that their use creates a false
sense of identity. To substantiate this claim, we discuss the long (and
poorly recorded) history of CHO cells as well as their highly complex
genetics. Finally, we suggest an alternative naming system for CHO cells
which provides more relevant information to the performance of these
cells. Implementation of such a system should improve interpretation and
comparability between laboratories. This, in turn will help scientific
communities and industrial users to attain the full potential of CHO
cells.